Poniard

NEWS
IRC 6045B Disclosure Documents - 1/17/2012
Poniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin Board - 1/3/2012
Poniard Pharmaceuticals and Allozyne Terminate Planned Merger - 12/22/2011
Poniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYN - 11/21/2011
 
Learn more about picoplatin, an investigational cancer therapy

Participate in clinical trials of picoplatin
 
EVENTS & PRESENTATIONS
 
Details on upcoming events are not yet available.
 
 

About Poniard | Picoplatin Overview & Market Opportunities | Investors | Contact Us